Brookfield Corp’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-36,187
Closed -$7.89M 685
2022
Q4
$7.89M Sell
36,187
-13,895
-28% -$3.03M 0.03% 181
2022
Q3
$9.86M Buy
50,082
+16,473
+49% +$3.56M 0.04% 161
2022
Q2
$7.19M Buy
33,609
+5,406
+19% +$1.32M 0.03% 196
2022
Q1
$8.01M Buy
28,203
+16,096
+133% +$4.96M 0.03% 187
2021
Q4
$4.56M Buy
12,107
+4,308
+55% +$1.67M 0.02% 232
2021
Q3
$3.22M Buy
7,799
+1,245
+19% +$517K 0.01% 280
2021
Q2
$2.42M Buy
+6,554
New +$2.19M 0.01% 330
2020
Q4
Sell
-8,562
Closed -$1.94M 455
2020
Q3
$1.94M Buy
+8,562
New +$1.78M 0.01% 249

Other funds holding CRL